Recent advances in (chemo-) radiation therapy for rectal cancer: a comprehensive review

F Roeder, E Meldolesi, S Gerum, V Valentini… - Radiation …, 2020 - Springer
The role of radiation therapy in the treatment of (colo)-rectal cancer has changed
dramatically over the past decades. Introduced with the aim of reducing the high rates of …

Inflammation and cancer: till death tears them apart

TP Raposo, BCB Beirão, LY Pang, FL Queiroga… - The Veterinary …, 2015 - Elsevier
Advances in biotechnology have enabled the collection of an immeasurable amount of
information from genomic, transcriptomic, metabolomic and proteomic studies of tumours …

Targeting the redox imbalance in mitochondria: A novel mode for cancer therapy

S Mani, G Swargiary, SJ Ralph - Mitochondrion, 2022 - Elsevier
Abstract Changes in reactive oxygen species (ROS) levels affect many aspects of cell
behavior. During carcinogenesis, moderate ROS production modifies gene expression to …

PTGS2 (Cyclooxygenase-2) expression and survival among colorectal cancer patients: a systematic review

AT Kunzmann, LJ Murray, CR Cardwell… - … Biomarkers & Prevention, 2013 - AACR
Background: Studies have examined whether tumor expression of PTGS2 (also known as
COX-2), an enzyme inhibited by nonsteroidal anti-inflammatory drugs such as aspirin, is …

Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial

J Li, J Ji, Y Cai, X Li, Y Li, H Wu, B Xu, F Dou… - Radiotherapy and …, 2012 - Elsevier
PURPOSE: We aimed to assess the safety and efficacy of preoperative intensity-modulated
radiotherapy (IMRT) with oral capecitabine in patients with locally advanced mid-low rectal …

[HTML][HTML] An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer

M Agostini, KP Janssen, E D'Angelo, S Pizzini… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Results The following specific gene signature, able to discriminate responders' patients from
non-responders, were founded: AKR1C3, CXCL11, CXCL10, IDO1, CXCL9, MMP12 and …

Regulatory T cells in radiotherapeutic responses

D Schaue, MW Xie, JA Ratikan, WH McBride - Frontiers in Oncology, 2012 - frontiersin.org
Radiation therapy (RT) can extend its influence in cancer therapy beyond what can be
attributed to in-field cytotoxicity by modulating the immune system. While complex, these …

The impact of anti-inflammatory agents on the outcome of patients with colorectal cancer

JH Park, DC McMillan, PG Horgan… - Cancer treatment reviews, 2014 - Elsevier
Although there is increasing appreciation of the role of the host inflammatory response in
determining outcome in patients in colorectal cancer, there has been little concerted effort to …

The efficacy and safety of celecoxib in addition to standard cancer therapy: a systematic review and meta-analysis of randomized controlled trials

SY Ye, JY Li, TH Li, YX Song, JX Sun, XW Chen… - Current …, 2022 - mdpi.com
The purpose of this meta-analysis was to evaluate the efficacy and safety of celecoxib, a
selective cyclooxygenase-2 (COX-2) inhibitor, in addition to standard anticancer therapy …

Development of antioxidant COX-2 inhibitors as radioprotective agents for radiation therapy—a hypothesis-driven review

M Laube, T Kniess, J Pietzsch - Antioxidants, 2016 - mdpi.com
Radiation therapy (RT) evolved to be a primary treatment modality for cancer patients.
Unfortunately, the cure or relief of symptoms is still accompanied by radiation-induced side …